Literature DB >> 819319

Influence of fixation and morphometric technics on capillary basement-membrane thickening prevalence data in diabetes.

J R Williamson, E Rowold, P Hoffman, C Kilo.   

Abstract

Muscle tissue obtained by needle biopsy from 20 diabetic subjects and from 20 age-matched control subjects was divided into two portions, one of which was fixed and processed by our routine procedure (primary glutaraldehyde fixation followed by osmium fixation and embedment in araldite) and the other was fixed initially in osmium tetroxide and embedded in maraglas, the procedure employed by Siperstein et al. Basement-membrane width of capillaries was measured by the 20-point method of Siperstein et al. and by the two-minimum-point technic developed in our own laboratory. Contrary to the experience of Siperstein et al., the prevalence of basement-membrane thickening in diabetic subjects based on mean width values and/or standard deviations in excess of 95 per cent tolerance intervals was highest (65 per cent) in minimum measurements of glutaraldehyde-fixed tissues and lowest (30 per cent) in osmium-fixed tissues (X2 = 4.9123, p less than 0.05). Internal discrepancies in the data of Siperstein et al. indicate that (1) their basement-membrane-width values derived from multiple measurements from control subjects are anomalous (low) and (2) the very high prevalence of basement-membrane thickening they reported in diabetic and in prediabetic subjects and considered as strong support for their conclusion that basement-membrane disease is independent of and precedes glucose intolerance is suspect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819319     DOI: 10.2337/diab.25.7.604

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Demonstration of uniform capillary basal lamina thickness by computer technology.

Authors:  D J Netto; P C Chen; S S Sobin; J Y Lee
Journal:  Ann Biomed Eng       Date:  1991       Impact factor: 3.934

2.  Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster.

Authors:  M Simionescu; D Popov; A Sima; M Hasu; G Costache; S Faitar; A Vulpanovici; C Stancu; D Stern; N Simionescu
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  A common sense approach resolves the basement membrane controversy and the NIH Pima Indian study.

Authors:  J R Williamson; C Kilo
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

Review 4.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

5.  Hyperglycaemia and diabetic microangiopathy.

Authors:  M D Siperstein; K R Feingold; P H Bennet
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

6.  Uremia in diabetics: the prognosis improves.

Authors:  E A Friedman; M M Beyer
Journal:  Klin Wochenschr       Date:  1980-10-01

7.  Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.

Authors:  S R Waltman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

8.  Electron microscopic observation of gastric mucosal capillaries in diabetics--relationship between diabetic microangiopathy and complications following gastrectomy.

Authors:  S Kihara; K Mori; M Akagi
Journal:  Gastroenterol Jpn       Date:  1983-06

9.  Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters.

Authors:  D Popov; M Simionescu; P R Shepherd
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

Review 10.  Control of the blood glucose in diabetes mellitus is it valuable? Is it feasible.

Authors:  R Bressler
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.